Mt. Everest RDT review

What is actually in it

Three ingredients, named openly, which is worth acknowledging: tadalafil, oxytocin and PT-141, in a sublingual rapid-dissolve tablet. Two strengths are sold, standard and MAX.

Only one of those three is a conventional ED drug. Tadalafil is the familiar PDE5 inhibitor with a long duration of action. The other two are doing something else entirely, and both deserve more explanation than the page gives them — which is none.

PT-141 is the ingredient to ask about

PT-141 is bremelanotide, a melanocortin agonist that acts on the brain rather than the blood vessels. It is a real drug with real regulatory status, and that status is specific: it is FDA-approved for premenopausal women with low sexual desire.

Prescribing it to men is off-label. Off-label prescribing is legal, common and often entirely appropriate — but it is a thing a buyer is entitled to be told, particularly when the drug is one of three in a product he is being sold as a package. The page does not mention it.

It is also associated with nausea, and it can raise blood pressure — which is a notable thing to combine with tadalafil, a drug that lowers it. None of that appears either.

The oxytocin question

Oxytocin is a nine-amino-acid peptide. Swallowed, it is broken down by digestive enzymes; absorbed through the lining of the mouth, uptake is poor and inconsistent.

There is no good evidence that sublingual oxytocin improves desire or erectile function. It appears in several products in this comparison and it is, as far as we can establish, doing more for the marketing than for the patient.

It says compounded, and stops there

Genuine credit where it is due: the page states “A compounded formulation combining Tadalafil, Oxytocin, and PT-141.” Several competitors sell compounded products while carefully avoiding the word.

But naming the category is not the disclosure. What a reader needs to know is what compounded *means* — that these preparations are not FDA-approved, that the FDA does not review them for safety, effectiveness or quality, and that they have not been shown to be therapeutically equivalent to the approved drug. The best page in this comparison writes all of that out. This one writes one adjective.

About that $3

“As low as $3 / Tbl” is the only number on either page, and it is a good one — genuinely cheaper per dose than most compounded multi-ingredient products we have audited, several of which charge four to eight times that.

But look at what is missing around it. No pack size. No dose count. No plan term. No renewal price. No statement of whether $3 is the introductory rate or the ongoing one, and no indication of what quantity you have to buy to reach it. 'As low as' is a floor, and a floor with nothing underneath it tells you very little. Why an advertised price and an affordable one are different questions.

The bottom line

The pricing is the most attractive thing in the compounded category, and the ingredient list is disclosed openly. Both of those count for something.

Neither counts for enough. A page selling a compounded tadalafil product to men over 50 without a nitrate warning has omitted the single fact most likely to matter, and a page selling PT-141 without saying it is approved only for women has omitted the second. Until both appear, there is no version of this we would send a reader to.